Comparisons

Ozari vs Sequence: Comparing Two GLP-1 Telehealth Options

Ozari vs Sequence: Comparing Two GLP-1 Telehealth Options

If you're exploring GLP-1 medications for weight loss, you've likely come across multiple telehealth providers offering Semaglutide and Tirzepatide. Two names that often come up are Ozari Health and Sequence. Both offer remote access to these medications, but they differ in pricing, approach, and what's included in their programs.

This comparison breaks down what each service offers so you can make an informed decision about your weight loss journey.

What Are Ozari and Sequence?

Both Ozari Health and Sequence are telehealth platforms specializing in weight loss medications, particularly GLP-1 receptor agonists like Semaglutide and Tirzepatide. These medications have gained significant attention for their effectiveness in helping people lose weight and manage metabolic health.

Ozari Health focuses on providing affordable access to compounded GLP-1 medications through a streamlined telehealth experience. Sequence, on the other hand, positions itself as a comprehensive weight loss program with additional support features.

Both services connect you with licensed healthcare providers who can evaluate your situation and prescribe appropriate medications if you qualify.

Medication Options: What Each Service Offers

When it comes to medication selection, both platforms offer access to the two most popular GLP-1 medications.

Ozari Health provides compounded Semaglutide and compounded Tirzepatide. These are formulated by licensed U.S. compounding pharmacies and contain the same active ingredients as their brand-name counterparts.

Sequence also offers access to both Semaglutide and Tirzepatide, working with compounding pharmacies to provide these medications to qualified patients.

The main difference isn't in what's available, but in how these services price and package their offerings.

Pricing Comparison: The Bottom Line

Price is often the deciding factor when choosing a telehealth GLP-1 provider, and this is where the two services differ most significantly.

Ozari Health offers compounded GLP-1 medications starting at $99/month. This straightforward pricing makes it one of the most affordable options in the telehealth GLP-1 space. The focus is on removing financial barriers to accessing these life-changing medications.

Sequence typically prices their programs at a higher monthly rate, often ranging from $200-$300+ per month depending on the medication and dosage. Their pricing reflects their positioning as a comprehensive program rather than a medication-only service.

For budget-conscious individuals or those without insurance coverage for weight loss medications, the price difference can be substantial over the course of a weight loss journey that may last several months or longer.

The Telehealth Experience

Both services operate entirely online, eliminating the need for in-person doctor visits.

With Ozari Health, the process is designed to be simple and quick. You complete a health intake, connect with a licensed provider, and if approved, your medication ships directly to your door. The emphasis is on accessibility and convenience without unnecessary complexity.

Sequence offers a similar telehealth model but includes additional program features like educational content, community support, and lifestyle coaching. Some patients appreciate these extras, while others prefer a more straightforward medication-focused approach.

Your preference here depends on what you're looking for. If you want additional support and community features, Sequence's approach might appeal to you. If you prefer a streamlined experience focused on medication access, Ozari's model may be a better fit.

Support and Ongoing Care

Managing GLP-1 therapy requires ongoing monitoring and dosage adjustments as you progress through your weight loss journey.

Both Ozari and Sequence provide access to healthcare providers for ongoing support. You can reach out with questions, discuss side effects, and adjust your treatment plan as needed.

The difference is in the additional layers of support. Sequence includes lifestyle coaching and community features as part of their program, while Ozari focuses on clinical care and provider access.

For more information about GLP-1 medications and weight loss, check out additional resources at ozarihealth.com/blog.

Who Should Choose Which Service?

Ozari Health might be right for you if:

Sequence might be right for you if:

Key Takeaways

Frequently Asked Questions

Are compounded GLP-1 medications as effective as brand-name versions?

Compounded Semaglutide and Tirzepatide contain the same active ingredients as Ozempic, Wegovy, Mounjaro, and Zepbound. They're made by licensed U.S. compounding pharmacies following strict quality standards. Many patients achieve excellent results with compounded medications at a fraction of the cost of brand-name options.

Can I switch from Sequence to Ozari or vice versa?

Yes, you can switch between telehealth providers. If you're already on a GLP-1 medication, you'll need to complete a new intake with your chosen provider. They'll review your current dosage and treatment history to ensure continuity of care. Just be mindful of timing to avoid gaps in your medication supply.

Do I need insurance to use Ozari or Sequence?

Neither service requires insurance. Both offer cash-pay options, which is actually how most patients access compounded GLP-1 medications since insurance rarely covers compounded versions. Ozari's $99/month starting price makes treatment accessible even without insurance coverage.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed providers and shipped to your door. Learn more at ozarihealth.com.

Reviewed by the Ozari Clinical Content Team (OCCT) — health writers and wellness professionals specializing in GLP-1 therapy and metabolic health. This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.